Advertisement

Topics

Latest "MAQUET Cardiovascular" News Stories

23:50 EDT 20th July 2018 | BioPortfolio

Here are the most relevant search results for "MAQUET Cardiovascular" found in our extensive news archives from over 250 global news sources.

More Information about MAQUET Cardiovascular on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about MAQUET Cardiovascular for you to read. Along with our medical data and news we also list MAQUET Cardiovascular Clinical Trials, which are updated daily. BioPortfolio also has a large database of MAQUET Cardiovascular Companies for you to search.

Showing "MAQUET Cardiovascular" News Articles 1–25 of 2,200+

Relevant

Traditional Chinese medicine is widely used for cardiovascular disease

(Cardiovascular Innovations and Applications) In this Letter to the Editor, the authors comment on a review article which assesses the efficacy and safety of TCM for cardiovascular disease, as well as the pharmacological effects of active TCM ingredients on the cardiovascular system and potential mechanisms.


Multivitamins Don't Appear to Boost Cardiovascular Health

Taking a daily multivitamin is not associated with lower risk for adverse cardiovascular outcomes, according to a meta-analysis in Circulation: Cardiovascular Quality and Outcomes...

Managing dyslipidaemia for the primary prevention of cardiovascular disease

What you need to knowAssess lipid status as part of an overall cardiovascular risk assessment using a risk calculatorRoutinely record a family history of premature cardiovascular disease, and...


Cardiovascular Nutrition Demystified

The authors of this review of key nutritional studies compiled evidence-based information on foods and dietary patterns that support cardiovascular health and demystified those that have incorrectly been identified as beneficial to cardiovascular health.

Media registration now open for TCT 2018

(Cardiovascular Research Foundation) Media registration is now open online for TCT 2018 (Transcatheter Cardiovascular Therapeutics), the annual Scientific Symposium of the Cardiovascular Research Foundation (CRF). TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine, attracting more than 10,000 attendees from 90 countries all over the world.

Racial/ethnic disparities in cardiovascular health persist in U.S. adults

1. Trends from 1988 to 2014 data suggest that for U.S. adults, cardiovascular health has worsened, and health disparities in race/ethnicity and nativity continue to exist. 2. Although cardiovascular health disparities between whites and African Americans or Mexican Americans have decreased, declining cardiovascular health among whites appears to be the reason for these decreases rather […]

FDA Issues Recall of Maquet Datascope CARDIOSAVE Hybrid IABPs

Fluids spilled on the consoles might seep inside and corrode circuit boards or otherwise cause the intra-aortic balloon pump systems to malfunction, regulators say. News Alerts

Targeting pathway may reduce cocaine's cardiovascular harms

(American Heart Association) Cocaine in mice increased levels of reactive oxygen species, molecules known to cause cardiovascular disease. Cocaine acts through microRNA (miR)-30c-5p, which leads to excess level of reactive oxygen species. Preventing activation of miR-30c-5p suppressed cocaine's harmful effects to the cardiovascular system, suggesting a potential treatment for cocaine-related cardi...

Global Cardiovascular Drugs Market Briefing 2018: Cardiovascular Drugs, Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Others – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Cardiovascular Drugs Market Global Briefing 2018” report has been added to ResearchAndMarkets.com’s offering. The Cardiovascular Drugs Market Global Briefing 2018 provides strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs … Continue reading → Cet articl...

Relation of Nutrition with Cardiovascular Health

Reporter and Curator: Dr. Sudipta Saha, Ph.D.   A heart-healthy diet has been the basis of atherosclerotic cardiovascular disease (ASCVD) prevention and treatment for decades. The potential cardiovascular (CV) benefits of specific individual components of the “food-ome” (defined as the vast array of foods and their constituents) are still incompletely understood, and nutritional science c...

Review: Plant-based diets associated with better cardiovascular health

Vegetarian, especially vegan, diets are associated with better cardiovascular health, according to a new review published in the journal Progress in Cardiovascular Diseases.

Portugal saves money with increased use of cardiovascular generics

Cardiovascular diseases are the primary cause of mortality worldwide [1-3], accounting for over 30% of all deaths. However, in the last few decades, the number of deaths attributed to cardiovascular diseases in higher-income countries has been on the decline. This is thought to be largely due to improved and increased healthcare interventions, according to Gama et al. [4].

Cardiovascular Risk Reduction

Cardiovascular risk reduction clinical information, medical news, and guidelines. Includes latest research, journal articles, Medscape TV, cases, quizzes, and peer discussion of cardiovascular risk. Medscape

Portugal increases use of generics for treatment of cardiovascular diseases

In Portugal, the use of medicines for cardiovascular system increased nearly two-fold between 2000 and 2010. As such, over a quarter of the overall expenditure on medicines during these years went towards the treatment of cardiovascular issues [1]. However, it is possible that there may be room for cost saving on these medicines through increased uptake of generic and essential medicines. A recent...

Expect much more from AstraZeneca in the cardiovascular space, says Elisabeth Björk

Cardiovascular (CV) disease is the world’s biggest killer that will demand a specific and concerted…

AHA: Limited Health Literacy Is Barrier to Cardiovascular Care

TUESDAY, June 5, 2018 -- Limited health literacy is a barrier to cardiovascular health and prevention of cardiovascular disease (CVD), according to a scientific statement from the American Heart Association published online June 4 in...

Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications

ABSTRACTRheumatoid arthritis is a systemic autoimmune disease characterized by excess morbidity and mortality from cardiovascular disease. Mechanisms linking rheumatoid arthritis and cardiovascular...

Global and North America Extracorporeal Membrane Oxygenation ECMO Systems Market Status and Future Forecast 20132023 [Report Updated: 22012018] Prices from USD $2500

SummaryKey Content of Chapters Including and can be customizedPart 1:Market Overview, Development, and Segment by Type, Application RegionPart 2:Global Market by company, Type, Application RegionPart 3:North America Market by company, Type, Application RegionPart 46:Key Regions of North America Market by Type, ApplicationPart 7:Company information, Sales, Cost, Margin etc.Part 8:ConclusionMarke...

Amarin’s REDUCE-IT Cardiovascular Outcomes Study Reaches 100% Mark for Estimated Onset of Target Primary Major Adverse Cardiovascular Events

BEDMINSTER, N.J., and DUBLIN, Ireland, April 04, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular health,  announced today that its REDUCE-IT cardiovascular outcomes study of Vascepa® (icosapent ethyl) is estimated to have reached the onset of the targeted 1,...

Highlights new issue of Cardiovascular Innovations and Applications Journal

(Cardiovascular Innovations and Applications) The Cardiovascular Innovations and Applications journal (CVIA) has just published an Special Issue on Valvular Heart Disease with Guest Editor Blase A. Carabello of East Carolina University. This contains several important case reports and reviews.

Associating frailty to cardiovascular disease and mortality

(Luxembourg Institute of Health) Frailty is common in elderly people with cardiovascular disease and goes along with elevated mortality. Dr. Gloria Aguayo from the Luxembourg Institute of Health (LIH) and co-workers examined the predictive ability of 35 frailty scores for cardiovascular disease, cancer and all-cause mortality using data from the English Longitudinal Study of Ageing. The analysis, ...

New study: LDL quality is a novel, modifiable cardiovascular risk marker

(University of Helsinki) The presence of sticky, aggregation-prone LDL in circulation is an independent predictor of cardiovascular death. This novel finding indicates that in addition to LDL-cholesterol levels, the quality of the cholesterol-carrying LDL particles also needs to be considered when estimating the cardiovascular risk of a person, say the researchers from the University of Helsinki a...

New Study Finds that Statins Prevent Cardiovascular Deaths

A new meta-analysis shows that statin drugs are effective at preventing cardiovascular events and death, especially in patients with a baseline LDL cholesterol >100.

Europe expands approved indication of Amgen's Repatha in cardiovascular disease

Amgen has revealed that its PCSK9 inhibitor Repatha (evolocumab) has received approval from the European Commission in a new indication: to reduce cardiovascular risk by lowering low-density lipoprotein cholesterol (LDL-C) levels in adult patients with established atherosclerotic cardiovascular disease, such as myocardial infarction, stroke or peripheral arterial disease. read more

Fitness, Exercise, and Coronary Calcification

Two new studies strongly confirm that physical activity reduces cardiovascular disease risk--and that CAC is a powerful predictor both of cardiovascular events and total mortality. Circulation


Advertisement
Quick Search
Advertisement
Advertisement

 

News Quicklinks